1383852-25-2

Upstream product

• 22282-99-1 4-bromo-2-methylpyridine 
• 1383852-24-1 5-bromo-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridine 
• 68-12-2 N,N-dimethyl-formamide 
• 121-98-2 methyl 4-methoxybenzoate 
• 1383852-22-9 2-(4-bromopyridin-2-yl)-1-(4-methoxyphenyl)ethanone 
• 1383852-23-0 2-(4-bromopyridin-2-yl)-1-(4-methoxyphenyl)ethanone oxime 
• 1391989-87-9 (Z)-2-(4-bromopyridin-2-yl)-1-(4-methoxyphenyl)ethanone oxime 
• 1391989-88-0 4-bromo-2-(3-(4-methoxyphenyl)-2H-azirin-2-yl)pyridine 
• 1391990-17-2 N-((5-bromo-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-3-yl)methylene)-N-methylmethanaminium chloride 

Downstream Products

• 1383852-32-1 3-(3-(5,6-dihydro-4H-1,2,4-oxadiazin-3-yl)-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-5-yl)-4-methylbenzoic acid 
• 1383852-21-8 3-[3-(5,6-dihydro-4H-1,2,4-oxadiazin-3-yl)-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-5-yl]-4-methyl-N-(1-phenylcyclopropyl)benzamide 
• 1383852-26-3 5-bromo-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridine-3-carbaldehyde oxime 
• 1383852-27-4 5-bromo-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridine-3-carbonitrile 
• 1383852-28-5 (Z)-5-bromo-N'-hydroxy-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridine-3-carboximidamide 
• 1383852-29-6 3-(5-bromo-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-3-yl)-1,2,4-oxadiazol-5(4H)-one 
• 1383852-30-9 3-(5-bromo-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-3-yl)-4-(2-chloroethyl)-1,2,4-oxadiazol-5(4H)-one 
• 1383852-31-0 3-(5-bromo-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-3-yl)-5,6-dihydro-4H-1,2,4-oxadiazine 
• 1391990-18-3 5-bromo-2-(4-methoxyphenyl)-3-(2-methoxyvinyl)pyrazolo[1,5-a]pyridine 

Relevant academic research and scientific papers

PYRAZOLOPYRIDINE AND PYRAZOLOPYRIMIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS

Disclosed herein is a compound of Formula I: wherein X, R1, R2, and R3 are as defend herein, or a pharmaceutically acceptable salt thereof to allow the drug to penetrate the cell membrane; or a prodrug, or the compound is labeled with a detectable label or an affinity tag thereof. Also disclosed is a pharmaceutical composition, a method of treating a disorder mediated by melanocortin-4 receptors, and a method of treating obesity using the compounds described.

HEPATITIS C INHIBITORS AND USES THEREOF

This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.